Assessment of Elevated Serum Tumor Markers Carcinoembryonic Antigen (CEA) and Cancer Antigen 15-3 (CA15-3) among Patients with Different Subtypes of Metastatic Breast Cancer
Background: Cancer antigen 15-3 and carcinoembryonic antigen are used in clinical and laboratory diagnosis of metastatic breast cancer. Previous studies have noted conflicting results about the association between carcinoembryonic antigen and cancer antigen 15-3 in metastatic breast cancer. The pres...
Main Authors: | Ali Taghizadeh, Leila Pourali, Mona Joudi, Maryam Salehi, Shohreh Eshghi, Farnaz Torabian, Azin Esmaeelpour |
---|---|
Format: | Article |
Language: | English |
Published: |
Shiraz University of Medical Sciences
2019-01-01
|
Series: | Middle East Journal of Cancer |
Online Access: | http://mejc.sums.ac.ir/article_44681_2bfbd886f9acf4228678f9b17149837d.pdf |
Similar Items
-
Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance
by: J.X. Hing, et al.
Published: (2020-08-01) -
Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes
by: Michiko Imamura, et al.
Published: (2018-02-01) -
The Carcinoembryonic Antigen (CEA): Past, Present, and Future
by: Phil Gold, et al.
Published: (2020-12-01) -
Role of serum carcinoembryonic antigen (CEA) as a tumor marker in breast cancer
by: Shahbaz Habib Faridi, et al.
Published: (2014-01-01) -
Determination of Cancer Antigen CA15-3 and Carcino Embryonic Antigen CEA concentration as Tumor Markers in Patients with Stomach and Colorectal cancers.
by: Rana. K. AL-saady, et al.
Published: (2012-10-01)